Andexanet Alfa–Induced Heparin Resistance: When Anticoagulation Really Remains Reversed-Reference-Cited by-同舟云学术

Andexanet Alfa–Induced Heparin Resistance: When Anticoagulation Really Remains Reversed

Published:2021-03 Issue:3 Volume:35 Page:908-909
ISSN:1053-0770
Container-title:Journal of Cardiothoracic and Vascular Anesthesia
language:en
Short-container-title:Journal of Cardiothoracic and Vascular Anesthesia

Author:

Erdoes Gabor,Birschmann Ingvild,Nagler Michael^ORCID,Koster Andreas

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: A review of design, development and potential place in therapy;Sartori;Thromb Thrombolysis,2018

2. Difficult intraoperative heparinization following andexanet alfa administration;Watson;Clin Pract Cases Emerg Med,2019

3. Intraoperative unfractionated heparin unresponsiveness during endovascular repair of a ruptured abdominal aortic aneurysm following administration of andexanet alfa for the reversal of rivaroxaban;Eche;Pharmacotherapy,2019

4. Assay-based differentiation in the neutralization profile of unfractionated heparin, enoxaparin, and fondaparinux by andexanet alfa;Siddiqui;J Clin Appl Thromb Hemost,2020

5. Andexanet alfa use in cardiac surgical patients: A xa inhibitor and heparin reversal agent;Levy;J Cardiothorac Vasc Anesth,2020

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro;British Journal of Anaesthesia;2024-06

2. Direct oral anticoagulants in trauma patients;Current Opinion in Anaesthesiology;2024-01-25

3. Grundlagen zur Anwendung von Andexanet;Hämostaseologie;2023-10-09

4. Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice;European Journal of Cardio-Thoracic Surgery;2023-10-01

5. Successful Nafamostat Mesilate Administration for Andexanet Alfa-Induced Heparin Resistance;Cureus;2023-08-23